Plain-English translation of NCT06831370 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether works well when combined with three other chemotherapy drugs (, , and ) to treat advanced Hodgkin lymphoma in adults who have never received cancer treatment before. Researchers want to understand how safe this four-drug combination is and how effectively it shrinks tumors.
Hodgkin lymphoma is a blood cancer that can be serious when it reaches advanced stages. While standard chemotherapy treatments exist, researchers are studying whether adding —a targeted cancer drug—to traditional chemotherapy may help patients in India respond better to treatment.
You likely qualify if…
You likely don't qualify if…
You would receive the medication combination for about 6 months, given through an IV infusion in cycles (repeating treatments every 4 weeks). Throughout your time in the study, you'll have regular blood tests and special heart and lung function tests to monitor how well the treatment is working and check for side effects. About 2 months after your final treatment, you'll return for a final health check-up.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
India